HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Kashiwagi Selected Research

Synovitis

10/2002Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Kashiwagi Research Topics

Disease

3Glomerulonephritis
06/2003 - 09/2002
2AIDS-Related Complex (ARC)
02/2012 - 06/2011
2Amyloidosis
03/2005 - 05/2000
2Nephrotic Syndrome (Syndrome, Nephrotic)
03/2005 - 09/2002
2IGA Glomerulonephritis (IGA Nephropathy)
06/2003 - 09/2002
2Hypertension (High Blood Pressure)
11/2002 - 09/2002
1Substance-Related Disorders (Drug Abuse)
01/2017
1Schizophrenia (Dementia Praecox)
01/2017
1Ascites
03/2005
1Immunoglobulin Light-chain Amyloidosis
03/2005
1Membranous Glomerulonephritis (Membranous Nephropathy)
06/2003
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
06/2003
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
06/2003
1Anemia
11/2002
1Pre-Eclampsia (Preeclampsia)
11/2002
1Synovitis
10/2002
1Rheumatoid Arthritis
10/2002
1Chronic Hepatitis C
09/2001
1Fibrosis (Cirrhosis)
09/2001
1Viremia
09/2001
1Hyperemia
05/2001
1Arthritis (Polyarthritis)
04/2001
1Inflammation (Inflammations)
02/2001
1Necrosis
02/2001
1Pancreatitis
02/2001
1Acute Necrotizing Pancreatitis
02/2001
1Neoplasms (Cancer)
10/2000
1Paralysis (Palsy)
06/2000
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
05/2000
1monomelic Amyotrophy
01/2000
1Muscular Atrophy (Muscle Atrophy)
01/2000

Drug/Important Bio-Agent (IBA)

2Amyloid (Amyloid Fibrils)IBA
03/2005 - 05/2000
2EnzymesIBA
03/2005 - 02/2001
2Prednisolone (Predate)FDA LinkGeneric
03/2005 - 09/2002
1KetamineFDA LinkGeneric
01/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017
1Glutamic Acid (Glutamate)FDA Link
01/2017
1Phencyclidine (Angel Dust)IBA
01/2017
1HydrogenIBA
02/2012
1Protons (Proton)IBA
06/2011
1Melphalan (Alkeran)FDA LinkGeneric
03/2005
1CytokinesIBA
06/2003
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
06/2003
1Hemoglobins (Hemoglobin)IBA
11/2002
1Saccharated Ferric Oxide (Venofer)FDA Link
11/2002
1ErythropoietinFDA Link
11/2002
1Tissue Inhibitor of Metalloproteinase-3IBA
10/2002
1Matrix Metalloproteinases (MMPs)IBA
10/2002
1Peptide Hydrolases (Proteases)FDA Link
10/2002
1Immunoglobulin A (IgA)IBA
09/2002
1StreptokinaseFDA Link
09/2002
1Collagen Type IV (Type IV Collagen)IBA
09/2001
1Hyaluronic Acid (Hyaluronan)IBA
09/2001
1Alanine Transaminase (SGPT)IBA
09/2001
1InterferonsIBA
09/2001
1aggrecanaseIBA
04/2001
1Aggrecans (Aggrecan)IBA
04/2001
1Metalloproteases (Metalloproteinases)IBA
04/2001
1Group II Phospholipases A2IBA
02/2001
1IsoenzymesIBA
02/2001
1Phospholipases (Phospholipase)IBA
02/2001
1Messenger RNA (mRNA)IBA
02/2001
1Protein Isoforms (Isoforms)IBA
02/2001
1Phospholipases A2 (Phospholipase A2)IBA
02/2001
1Phosphotransferases (Kinase)IBA
10/2000
1Cyclin-Dependent Kinase Inhibitor p16IBA
10/2000
1Indicators and Reagents (Reagents)IBA
06/2000
1Therapeutic UsesIBA
01/2000

Therapy/Procedure

4Therapeutics
11/2002 - 05/2001
2Renal Dialysis (Hemodialysis)
03/2005 - 05/2000
2Aftercare (After-Treatment)
09/2001 - 01/2000
1Cesarean Section (Caesarean Section)
11/2002